1. Home
  2. ARWR vs PFS Comparison

ARWR vs PFS Comparison

Compare ARWR & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • PFS
  • Stock Information
  • Founded
  • ARWR 2003
  • PFS 1839
  • Country
  • ARWR United States
  • PFS United States
  • Employees
  • ARWR N/A
  • PFS N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • PFS Savings Institutions
  • Sector
  • ARWR Health Care
  • PFS Finance
  • Exchange
  • ARWR Nasdaq
  • PFS Nasdaq
  • Market Cap
  • ARWR 2.5B
  • PFS 2.8B
  • IPO Year
  • ARWR 1993
  • PFS N/A
  • Fundamental
  • Price
  • ARWR $18.57
  • PFS $21.26
  • Analyst Decision
  • ARWR Buy
  • PFS Strong Buy
  • Analyst Count
  • ARWR 11
  • PFS 4
  • Target Price
  • ARWR $45.33
  • PFS $22.00
  • AVG Volume (30 Days)
  • ARWR 997.3K
  • PFS 630.3K
  • Earning Date
  • ARWR 11-26-2024
  • PFS 10-29-2024
  • Dividend Yield
  • ARWR N/A
  • PFS 4.49%
  • EPS Growth
  • ARWR N/A
  • PFS N/A
  • EPS
  • ARWR N/A
  • PFS 0.98
  • Revenue
  • ARWR $19,648,000.00
  • PFS $526,013,000.00
  • Revenue This Year
  • ARWR N/A
  • PFS N/A
  • Revenue Next Year
  • ARWR $100.95
  • PFS $27.36
  • P/E Ratio
  • ARWR N/A
  • PFS $21.86
  • Revenue Growth
  • ARWR N/A
  • PFS 13.26
  • 52 Week Low
  • ARWR $17.05
  • PFS $13.07
  • 52 Week High
  • ARWR $39.83
  • PFS $22.23
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 35.87
  • PFS 64.78
  • Support Level
  • ARWR $21.20
  • PFS $21.15
  • Resistance Level
  • ARWR $22.03
  • PFS $22.23
  • Average True Range (ATR)
  • ARWR 0.87
  • PFS 0.53
  • MACD
  • ARWR -0.04
  • PFS 0.17
  • Stochastic Oscillator
  • ARWR 0.76
  • PFS 81.22

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: